Global Pharmaceuticals & Biotech Breakout Stocks

Natera

Market Cap: US$46.3b

A diagnostics company, engages in the development and commercialization of molecular testing services worldwide.

Insmed

Market Cap: US$28.6b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Halozyme Therapeutics

Market Cap: US$11.7b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally.

Twist Bioscience

Market Cap: US$7.3b

Manufactures and sells synthetic DNA-based products.

Iovance Biotherapeutics

Market Cap: US$2.9b

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally.

Viridian Therapeutics

Market Cap: US$2.7b

Engages in discovering, developing, and commercializing treatments for serious and rare diseases.

UroGen Pharma

Market Cap: US$2.3b

A biotechnology company, engages in the development and commercialization of solutions for urothelial and specialty cancers.

Pell Bio-Med Technology

Market Cap: NT$63.3b

A biomedical company, engages in the research, development, manufacturing, and sales of chimeric antigen recombinant T cell (CAR-T), and other related services and products.

Neuren Pharmaceuticals

Market Cap: AU$2.7b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

Alivus Life Sciences

Market Cap: ₹162.7b

Develops, manufactures, and markets active pharmaceutical ingredients in India, Japan, Europe, North and Latin America, and internationally.

Lin BioScience

Market Cap: NT$52.8b

A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.

Sino BiologicalInc

Market Cap: CN¥10.9b

Engages in the provision of recombinant protein and antibody reagents for life science researchers in China and internationally.

Shilpa Medicare

Market Cap: ₹144.7b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

PYC Therapeutics

Market Cap: AU$2.1b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

ORIC Pharmaceuticals

Market Cap: US$1.4b

A clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States.

Cybin

Market Cap: US$719.6m

Cybin Inc., doing business as Helus Pharma, a clinical stage pharmaceutical company, focuses on developing therapies to treat various psychiatric and neurological conditions.It develops HLP003, a deuterated psilocybin analog, which is in phase 3 clinical trial to treat major depressive disorder (MDD); and HLP004, a deuterated N, N-dimethyltryptamine (DMT), which is in phase 2 clinical trial for treating generalized anxiety disorders.

Zhejiang Wecome Pharmaceutical

Market Cap: CN¥4.8b

Engages in the research and development, production, and sale of modern Chinese and western medicine in China.

GlaxoSmithKlineE

Market Cap: ج.م33.2b

Engages in production of pharmaceutical chemicals.

Sagimet Biosciences

Market Cap: US$559.5m

A clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic and fibrotic pathways in the United States.

Xinjiang Bai Hua Cun Pharma TechLtd

Market Cap: CN¥3.7b

Engages in pharmaceutical research and development, clinical trials, biomedicine, commercial properties, and other businesses.

Evolus

Market Cap: US$501.3m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

ACRO Biomedical

Market Cap: NT$15.0b

Develops medical-grade regenerative biomaterials in Taiwan, Vietnam, and internationally.

Morepen Laboratories

Market Cap: ₹43.6b

Develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.

OmniAb

Market Cap: US$446.5m

A biotechnology company, licenses discovery research technology to pharmaceutical and biotech companies, and academic institutions to enable the discovery of therapeutics in the United States, Europe, Japan, China, and Canada.

Fennec Pharmaceuticals

Market Cap: US$402.1m

Operates as a commercial stage biopharmaceutical company in the United States.

Foghorn Therapeutics

Market Cap: US$360.5m

A clinical-stage biopharmaceutical company, engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system in the United States.

Alpha Teknova

Market Cap: US$346.8m

Produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

TriSalus Life Sciences

Market Cap: US$345.4m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers in the United States.

EI- Nile for Pharmaceuticals and Chemical Industries

Market Cap: ج.م15.5b

Develops, produces, and sells pharmaceutical products in Egypt.

Whitehawk Therapeutics

Market Cap: US$271.4m

A clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.

AVITA Medical

Market Cap: US$239.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Pyxis Oncology

Market Cap: US$236.3m

A clinical stage company, engages in the development of therapeutics to treat solid tumors.

Fredun Pharmaceuticals

Market Cap: ₹20.2b

Manufactures and sells pharmaceutical formulations, dietary/herbal supplements, nutraceuticals, animal healthcare products, cosmeceuticals, mobility and rehabilitation products, and other healthcare products in India, Africa, Southeast Asia, Commonwealth of Independent States countries, MENA region, and Latin America.

Japan Tissue Engineering

Market Cap: JP¥32.4b

Engages in the regenerative medicine business in Japan.

PepGen

Market Cap: US$197.1m

A clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States.

Tien Liang BioTech

Market Cap: NT$3.9b

Manufactures and sells pharmaceutical products in Taiwan.